The CALIBER Study Randomized Controlled Trial of LINX Versus Double-Dose Proton Pump Inhibitor Therapy for Reflux Disease

NCT02505945 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

152

Enrollment

INDUSTRY

Sponsor class

Conditions

GERD Gastroesophageal Reflux Disease

Interventions

DRUG: Omeprazole
DEVICE: LINX Reflux Management System

Sponsor

Torax Medical Incorporated